XML 55 R38.htm IDEA: XBRL DOCUMENT
v3.25.4

Common Stock, Stock Options, Restricted Stock Awards, and Warrants - Schedule of Exercise of Outstanding Warrants (Details) | Sep. 30, 2025 $ / shares shares
--- | ---
August 2018 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 28.75
Number | 156,863
Expiration Dates | Aug. 14, 2026
August 2018 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 39.84
Number | 7,576
Expiration Dates | Aug. 08, 2026
September 2019 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 19.25
Number | 111,732
Expiration Dates | Sep. 27, 2026
September 2019 Offering Underwriter [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 27.97
Number | 7,774
Expiration Dates | Sep. 27, 2026
May 2020 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 25
Number | 66,824
Expiration Dates | Nov. 18, 2025
January 2021 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 30.78
Number | 123,648
Expiration Dates | Jul. 27, 2026
January 2021 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 40.44
Number | 14,065
Expiration Dates | Jul. 27, 2026
February 2021 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 42.5
Number | 823,211
Expiration Dates | Feb. 19, 2026
February 2021 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 47.03
Number | 100,256
Expiration Dates | Feb. 19, 2026
May 2023 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 37.5
Number | 500,000
Expiration Dates | May 08, 2028
May 2023 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 37.5
Number | 35,000
Expiration Dates | May 03, 2028
April 2024 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 18.75
Number | 857,143
Expiration Dates | Oct. 30, 2029
April 2024 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 21.875
Number | 60,000
Expiration Dates | Apr. 25, 2029
November 2024 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 6.25
Number | 480,000
Expiration Dates | Nov. 18, 2029
November 2024 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 7.8125
Number | 33,600
Expiration Dates | Nov. 15, 2029
January 2025 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 3.91
Number | 743,496
Expiration Dates | Jan. 08, 2030
January 2025 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 5.0438
Number | 52,045
Expiration Dates | Jan. 07, 2030
April 2025 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.4375
Number | 121,739
Expiration Dates | Apr. 01, 2030
June 2025 Offering Investor [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1
Number | 9,840,000
Expiration Dates | Jun. 11, 2027
June 2025 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.525
Number | 344,400
Expiration Dates | Jun. 11, 2027
July 2025 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.32
Number | 6,818,182
Expiration Dates | Jul. 17, 2030
July 2025 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.65
Number | 272,727
Expiration Dates | Jul. 17, 2030
July 2025 Prior Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.65
Number | 477,273
Expiration Dates | Jul. 17, 2030
September 2025 Offering Investors [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.84
Number | 5,142,858
Expiration Dates | Mar. 10, 2031
September 2025 Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 1.92
Number | 205,714
Expiration Dates | Mar. 10, 2031
September 2025 Prior Offering Agent [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Exercise price (in Dollars per share) | $ / shares | $ 2.1875
Number | 360,000
Expiration Dates | Mar. 10, 2031
Citius Pharmaceuticals Warrants [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Number | 14,479,372
Citius Oncology Warrants [Member] |
Schedule of Exercise of Outstanding Warrants [Line Items] |
Number | 13,276,754

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_August2018OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_August2018OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_September2019OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_September2019OfferingUnderwriterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_May2020OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_January2021OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_January2021OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_February2021OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_February2021OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_May2023OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_May2023OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_April2024OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_April2024OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_November2024OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_November2024OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_January2025OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_January2025OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_April2025OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_June2025OfferingInvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_June2025OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_July2025OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_July2025OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_July2025PriorOfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_September2025OfferingInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_September2025OfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ctxr_September2025PriorOfferingAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ctxr_CitiusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ctxr_CitiusOncologyWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |